Logo image of PET

WAG! GROUP CO (PET) Stock Fundamental Analysis

USA - NASDAQ:PET - US93042P1093 - Common Stock

0.0469 USD
-0.07 (-59.91%)
Last: 7/29/2025, 8:11:09 PM
0.0489 USD
+0 (+4.26%)
After Hours: 7/29/2025, 8:11:09 PM
Fundamental Rating

2

PET gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 75 industry peers in the Diversified Consumer Services industry. PET may be in some trouble as it scores bad on both profitability and health. PET is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PET has reported negative net income.
In the past year PET has reported a negative cash flow from operations.
In the past 5 years PET always reported negative net income.
PET had a negative operating cash flow in each of the past 5 years.
PET Yearly Net Income VS EBIT VS OCF VS FCFPET Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

PET's Return On Assets of -63.17% is on the low side compared to the rest of the industry. PET is outperformed by 84.72% of its industry peers.
Industry RankSector Rank
ROA -63.17%
ROE N/A
ROIC N/A
ROA(3y)-53.98%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PET Yearly ROA, ROE, ROICPET Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10K 20K 30K

1.3 Margins

The Gross Margin of PET (90.43%) is better than 98.61% of its industry peers.
The Profit Margin and Operating Margin are not available for PET so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 90.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PET Yearly Profit, Operating, Gross MarginsPET Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 50 -50

More info and screens

0

2. Health

2.1 Basic Checks

PET does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PET has been increased compared to 1 year ago.
Compared to 1 year ago, PET has a worse debt to assets ratio.
PET Yearly Shares OutstandingPET Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M 50M
PET Yearly Total Debt VS Total AssetsPET Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

PET has an Altman-Z score of -8.86. This is a bad value and indicates that PET is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -8.86, PET is not doing good in the industry: 80.56% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.86
ROIC/WACCN/A
WACC14.15%
PET Yearly LT Debt VS Equity VS FCFPET Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.46 indicates that PET may have some problems paying its short term obligations.
PET's Current ratio of 0.46 is on the low side compared to the rest of the industry. PET is outperformed by 81.94% of its industry peers.
PET has a Quick Ratio of 0.46. This is a bad value and indicates that PET is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.46, PET is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.46
Quick Ratio 0.46
PET Yearly Current Assets VS Current LiabilitesPET Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

3

3. Growth

3.1 Past

PET shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.88%.
Looking at the last year, PET shows a very negative growth in Revenue. The Revenue has decreased by -27.81% in the last year.
EPS 1Y (TTM)-5.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.11%
Revenue 1Y (TTM)-27.81%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-34.67%

3.2 Future

PET is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 47.42% yearly.
PET is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 36.72% yearly.
EPS Next Y22.09%
EPS Next 2Y47.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.88%
Revenue Next 2Y46.15%
Revenue Next 3Y36.72%
Revenue Next 5YN/A

3.3 Evolution

PET Yearly Revenue VS EstimatesPET Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
PET Yearly EPS VS EstimatesPET Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

PET reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 0.77, the valuation of PET can be described as very cheap.
Based on the Price/Forward Earnings ratio, PET is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
PET's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.21.
Industry RankSector Rank
PE N/A
Fwd PE 0.77
PET Price Earnings VS Forward Price EarningsPET Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PET Per share dataPET EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PET's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as PET's earnings are expected to grow with 47.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.42%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PET!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WAG! GROUP CO

NASDAQ:PET (7/29/2025, 8:11:09 PM)

After market: 0.0489 +0 (+4.26%)

0.0469

-0.07 (-59.91%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-10 2025-11-10/bmo
Inst Owners54.46%
Inst Owner Change0%
Ins Owners9.25%
Ins Owner Change-15.85%
Market Cap2.38M
Analysts45
Price Target0.51 (987.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-59.83%
Min EPS beat(2)-78.22%
Max EPS beat(2)-41.44%
EPS beat(4)1
Avg EPS beat(4)-74.8%
Min EPS beat(4)-197.03%
Max EPS beat(4)17.49%
EPS beat(8)3
Avg EPS beat(8)-36.46%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-20.66%
Min Revenue beat(2)-22.18%
Max Revenue beat(2)-19.15%
Revenue beat(4)0
Avg Revenue beat(4)-23.87%
Min Revenue beat(4)-37.45%
Max Revenue beat(4)-16.7%
Revenue beat(8)4
Avg Revenue beat(8)-9.76%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.77
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.36
EYN/A
EPS(NY)0.06
Fwd EY129.21%
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS1.23
BVpS-0.07
TBVpS-0.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -63.17%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 90.43%
FCFM N/A
ROA(3y)-53.98%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover2.17
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 79.27%
Cap/Sales 3.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.46
Quick Ratio 0.46
Altman-Z -8.86
F-Score4
WACC14.15%
ROIC/WACCN/A
Cap/Depr(3y)35.99%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.04%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.11%
EPS Next Y22.09%
EPS Next 2Y47.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.81%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-34.67%
Revenue Next Year-3.88%
Revenue Next 2Y46.15%
Revenue Next 3Y36.72%
Revenue Next 5YN/A
EBIT growth 1Y-81.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year172.52%
EBIT Next 3Y88.18%
EBIT Next 5YN/A
FCF growth 1Y-83.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-39.56%
OCF growth 3YN/A
OCF growth 5YN/A